0001140361-15-023160.txt : 20150603
0001140361-15-023160.hdr.sgml : 20150603
20150603202334
ACCESSION NUMBER: 0001140361-15-023160
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150531
FILED AS OF DATE: 20150603
DATE AS OF CHANGE: 20150603
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC
CENTRAL INDEX KEY: 0001048477
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 680397820
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
BUSINESS PHONE: 4155066700
MAIL ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ajer Jeffrey Robert
CENTRAL INDEX KEY: 0001557533
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26727
FILM NUMBER: 15911653
MAIL ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
4
1
doc1.xml
FORM 4
X0306
4
2015-05-31
0
0001048477
BIOMARIN PHARMACEUTICAL INC
BMRN
0001557533
Ajer Jeffrey Robert
C/O BIOMARIN PHARMACEUTICAL INC.,
770 LINDARO ST.
SAN RAFAEL
CA
94901
0
1
0
0
SVP, Chief Commercial Of
Common Stock
2015-05-31
2015-05-31
4
F
0
413
125.57
D
38832
D
Common Stock
2015-06-01
2015-06-01
4
S
0
377
123.7582
D
38455
D
This transaction, which should have been reported on June 2, 2015, is being reported late due to an administrative oversight.
Trade made pursuant to a 10b5-1 plan executed Mayy 11, 2015
The price in column 4 is a weighted average price. The price actually received ranged from $123.06 to $124.18. Th reporting person shall provide to the issuer, and security holder of the issuer, or the SEC staff upon request, information regarding the number of shares sold at each price within the range.
/s/ Laura Randall Woodhead, Attorney-in-Fact
2015-06-03